Novo Nordisk launches Wegovy for chronic weight management and cardiovascular risk reduction in… EP News Bureau Jun 24, 2025 Wegovy, a once-weekly semaglutide injection, is reportedly the first GLP-1 receptor agonist in India approved for both long-term…
